Why is "it worked for me" not evidence of anything analytical?

This is a first order from this supplier, so I have no track record to reason from.

The empirical answer seems settled. The explanation does not.

If the honest answer is that nobody knows, I would rather hear that than a plausible story.

Is the standard explanation correct, and if so, what is the evidence for it?

The relevant framing is that risk here comes from three separate places: what the material is, how it is handled, and what it does. They need three different mitigations.

Know the symptoms that end the discussion: severe epigastric pain radiating to the back, persistent vomiting with reduced urine output, spreading redness with fever, jaundice, chest pain or breathlessness.

Do not combine unknowns. Adding a second unverified compound while assessing the first makes any observation uninterpretable and doubles the exposure.

Tell a clinician. It is the decision that makes every other problem solvable.

The short version: independent testing, conservative titration, sterile-ish technique, a written record and a clinician who knows.

Tell a clinician. The most common reason a problem becomes serious in this space is that the person having it withheld the relevant fact from the person who could have helped.

Have a plan for stopping before you start, including what you would do with the remaining material and how you would tell someone what you had taken.

Start lower and go slower than the label. Time costs nothing here.

Answering this needs to know what is already in place, because the marginal value of each step depends on which are missing.

Handling risk is reduced by aseptic technique, minimising stopper entries, refrigerating after reconstitution and discarding on any change in appearance. None of it makes a preparation sterile.

Keep a written log: date, dose, lot, site, and anything noticed. It converts an anecdote into a record and is what makes any later consultation productive.

Keep a written log with lot numbers. It is what a professional can actually use.

Specifically, this is the tag where the community is at its most useful, because most of the advice costs nothing.

Material risk is reduced by independent testing: identity, purity and quantified content on your own lot, before committing to a larger order. That is the only step that addresses what is actually in the vial.

Slower titration than the licensed schedule reduces gastrointestinal adverse events, which is the mechanism the licensed schedules themselves rely on.

Nothing here is medical advice, and research-use compounds are not approved for human use in any jurisdiction.

Test your own material. Everything else is downstream of knowing what it is.

Start with the fact that nothing in this space is risk-free and that the useful question is which risks are reducible at what cost.

Pharmacological risk is reduced by starting below the lowest licensed step and escalating more slowly than the label schedule. Time is the cheapest resource in this whole calculation.

The caveat is that harm reduction reduces harm and does not eliminate it, and the category risk of unapproved material cannot be mitigated away.

Learn the handful of symptoms that end the discussion and start a clinical one.